PIM
KRSA

Penobscot Investment Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Penobscot Investment Management’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-71
Closed -$4.34K – 234
2023
Q1 		$4.34K Buy
+71
New +$896 ﹤0.01% 224

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Penobscot Investment Management's KRSA Position: Q2 2023 in Review

Penobscot Investment Management sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2023, closing a stake of 71 shares — an estimated $4.34K sold.

Penobscot Investment Management first reported a position in KRSA in Q1 2023 and held it in 1 quarter. The position peaked at $4.34K in Q1 2023. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

  • Penobscot Investment Management reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Penobscot Investment Management sold 71 Korsana Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $4.34K.
  • Penobscot Investment Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Penobscot Investment Management's Korsana Biosciences, Inc. Common Stock position peaked at $4.34K in Q1 2023.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2023.

Based on Penobscot Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.